INSTITUTO CIENTÍFICO PARA LA MEDICINA PERSONALIZADA, S.A.P.I. DE C.V. – Trademark Portfolio
Entity Type: 03
INSTITUTO CIENTÍFICO PARA LA MEDICINA PERSONALIZADA, S.A.P.I. DE C.V. has 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Filings span 3 Nice Classification classes, led by Class 42 (Computer & Scientific) and Class 41 (Education & Entertainment). This trademark owner is based in Nuevo León.
JoséClementeOrozco#329TorreHeliconPiso24
Nuevo León 66269 , MX
Showing of trademarks Trademarks
Trademark Classifications
INSTITUTO CIENTÍFICO PARA LA MEDICINA PERSONALIZADA, S.A.P.I. DE C.V.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does INSTITUTO CIENTÍFICO PARA LA MEDICINA PERSONALIZADA, S.A.P.I. DE C.V. have?
INSTITUTO CIENTÍFICO PARA LA MEDICINA PERSONALIZADA, S.A.P.I. DE C.V. has 3 U.S. trademarks filed with the USPTO.
What trademark classes does INSTITUTO CIENTÍFICO PARA LA MEDICINA PERSONALIZADA, S.A.P.I. DE C.V. file in?
INSTITUTO CIENTÍFICO PARA LA MEDICINA PERSONALIZADA, S.A.P.I. DE C.V. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What is INSTITUTO CIENTÍFICO PARA LA MEDICINA PERSONALIZADA, S.A.P.I. DE C.V.'s trademark registration success rate?
INSTITUTO CIENTÍFICO PARA LA MEDICINA PERSONALIZADA, S.A.P.I. DE C.V. has a 0% trademark registration rate, with 0 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.